ARTICLE | Company News
Cortecs International Ltd. deal
December 19, 1994 8:00 AM UTC
The London company arranged a three-year, £1.6 million R&D syndication deal in Australia to fund further develop DLVRY's Pseudostat and Moniliastat oral therapeutic vaccines. Pseudostat is being devel...